Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Refractory Germ Cell Malignancies
NCT00036842Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in Testicular Germ Cell Tumor (TGCT), extragonadal germ cell tumor (EGGCT), sponsored by SWOG Cancer Research Network. Started Apr 2002; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
Testicular Germ Cell Tumor (TGCT)extragonadal germ cell tumor (EGGCT)
Beyond the preview
Go deeper on NCT00036842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036842.